Disease

Analysis: Pandemic fatigue makes the case for boosters a harder sell

Some nations are already looking to a fourth vaccine dose to help contend with a huge Omicron-driven spike in COVID-19…

4 years ago

Uber to let office staff work up to half their time from anywhere -source

Uber Technologies Inc (UBER.N) will let employees work half their hours from wherever they want as part of its revamped…

4 years ago

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now.

4 years ago

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now.

4 years ago

U.S. approval of Biogen Alzheimer’s drug sends shares soaring, hailed as ‘big day” for patients

U.S. regulators on Monday approved Biogen Inc's (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer's…

4 years ago

AstraZeneca moves finance chief to new role after Alexion deal

AstraZeneca (AZN.L) will move finance chief Marc Dunoyer to head newly acquired rare diseases business Alexion (ALXN.O), using the $39…

4 years ago

UK competition regulator looking into $39 bln AstraZeneca-Alexion deal

Britain's competition regulator is reviewing AstraZeneca's (AZN.L) $39 billion buyout of U.S.-based Alexion (ALXN.O) on concerns it could reduce competition…

5 years ago